KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to 0.56.

  • Dynavax Technologies' Equity Ratio fell 1205.09% to 0.56 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.56, marking a year-over-year decrease of 1205.09%. This contributed to the annual value of 0.61 for FY2024, which is 300.83% down from last year.
  • Per Dynavax Technologies' latest filing, its Equity Ratio stood at 0.56 for Q3 2025, which was down 1205.09% from 0.54 recorded in Q2 2025.
  • Dynavax Technologies' Equity Ratio's 5-year high stood at 0.64 during Q3 2024, with a 5-year trough of 0.07 in Q3 2021.
  • For the 5-year period, Dynavax Technologies' Equity Ratio averaged around 0.47, with its median value being 0.56 (2025).
  • As far as peak fluctuations go, Dynavax Technologies' Equity Ratio plummeted by 6252.27% in 2021, and later soared by 58173.71% in 2022.
  • Over the past 5 years, Dynavax Technologies' Equity Ratio (Quarter) stood at 0.21 in 2021, then skyrocketed by 175.43% to 0.59 in 2022, then grew by 5.86% to 0.62 in 2023, then decreased by 3.01% to 0.61 in 2024, then decreased by 6.74% to 0.56 in 2025.
  • Its last three reported values are 0.56 in Q3 2025, 0.54 for Q2 2025, and 0.56 during Q1 2025.